Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Oct 1. pii: ASN.2019040331. doi: 10.1681/ASN.2019040331. [Epub ahead of print]

PMID:
31575699
2.

Prevalence of asymptomatic bacteriuria among kidney transplant recipients beyond two months post-transplant: A multicenter, prospective, cross-sectional study.

Coussement J, Scemla A, Hougardy JM, Sberro-Soussan R, Amrouche L, Catalano C, Johnson JR, Abramowicz D.

PLoS One. 2019 Sep 6;14(9):e0221820. doi: 10.1371/journal.pone.0221820. eCollection 2019.

3.

Central nervous system complications in adult cystinosis patients.

Servais A, Saitovitch A, Hummel A, Boisgontier J, Scemla A, Sberro-Soussan R, Snanoudj R, Lemaitre H, Legendre C, Pontoizeau C, Antignac C, Anglicheau D, Funalot B, Boddaert N.

J Inherit Metab Dis. 2019 Aug 24. doi: 10.1002/jimd.12164. [Epub ahead of print]

PMID:
31444911
4.

The Case | Posttransplant upper limb inflammatory nodules.

Brunel M, Leclerc-Mercier S, Barnier JP, Bille E, Sberro-Soussan R, Legendre C, Scemla A.

Kidney Int. 2019 Mar;95(3):721-722. doi: 10.1016/j.kint.2018.10.012. No abstract available.

PMID:
30784666
5.

Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies.

Ulloa CE, Anglicheau D, Snanoudj R, Scemla A, Martinez F, Timsit MO, Legendre C, Sberro-Soussan R.

Transplantation. 2019 Oct;103(10):2150-2156. doi: 10.1097/TP.0000000000002592.

PMID:
30720681
6.

Baseline graft status is a critical predictor of kidney graft failure after diarrhoea.

Devresse A, Morin L, Aulagnon F, Taupin JL, Scemla A, Lanternier F, Aubert O, Aidoud AA, Lebreton X, Sberro-Soussan R, Snanoudj R, Amrouche L, Tinel C, Martinez F, Bererhi L, Anglicheau D, Lortholary O, Legendre C, Avettand-Fenoel V, Zuber J.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1597-1604. doi: 10.1093/ndt/gfy386.

PMID:
30608553
7.

Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults.

Gribouval O, Boyer O, Hummel A, Dantal J, Martinez F, Sberro-Soussan R, Etienne I, Chauveau D, Delahousse M, Lionet A, Allard J, Pouteil Noble C, Tête MJ, Heidet L, Antignac C, Servais A.

Kidney Int. 2018 Nov;94(5):1013-1022. doi: 10.1016/j.kint.2018.07.024.

PMID:
30348286
8.

Conversion to Belatacept in Maintenance Kidney Transplant Patients: A Retrospective Multicenter European Study.

Darres A, Ulloa C, Brakemeier S, Garrouste C, Bestard O, Del Bello A, Sberro Soussan R, Dürr M, Budde K, Legendre C, Kamar N.

Transplantation. 2018 Sep;102(9):1545-1552. doi: 10.1097/TP.0000000000002192.

PMID:
29570163
9.

Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study.

Mallet V, Sberro-Soussan R, Roque-Afonso AM, Vallet-Pichard A, Deau B, Portal A, Chaix ML, Hauser L, Beylouné A, Mercadier A, Izopet J, Legendre C, Pol S.

Transplantation. 2018 Aug;102(8):1351-1357. doi: 10.1097/TP.0000000000002185.

PMID:
29561324
10.

The role of complement inhibition in kidney transplantation.

Legendre C, Sberro-Soussan R, Zuber J, Frémeaux-Bacchi V.

Br Med Bull. 2017 Dec 1;124(1):5-17. doi: 10.1093/bmb/ldx037. Review.

PMID:
29069327
11.

Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.

Levi C, Frémeaux-Bacchi V, Zuber J, Rabant M, Devriese M, Snanoudj R, Scemla A, Amrouche L, Mejean A, Legendre C, Sberro-Soussan R.

Transplantation. 2017 Dec;101(12):2924-2930. doi: 10.1097/TP.0000000000001909.

PMID:
28858176
12.

Paraganglioma of the bladder in a kidney transplant recipient: A case report.

Lazareth H, Cohen D, Vasiliu V, Tinel C, Martinez F, Grünfeld JP, Mamzer MF, Legendre C, Sberro-Soussan R.

Mol Clin Oncol. 2017 Apr;6(4):553-555. doi: 10.3892/mco.2017.1182. Epub 2017 Mar 6.

13.

Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program.

Amrouche L, Aubert O, Suberbielle C, Rabant M, Van Huyen JD, Martinez F, Sberro-Soussan R, Scemla A, Tinel C, Snanoudj R, Zuber J, Cavalcanti R, Timsit MO, Lamhaut L, Anglicheau D, Loupy A, Legendre C.

Transplantation. 2017 Oct;101(10):2440-2448. doi: 10.1097/TP.0000000000001650.

PMID:
28114171
14.

Prognosis of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study.

Desbois AC, Poiree S, Snanoudj R, Bougnoux ME, Sberro-Soussan R, Lanternier F, Legendre C, Lortholary O, Scemla A.

Transplant Direct. 2016 Jul 1;2(8):e90. eCollection 2016 Aug.

15.

Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report.

Mallet V, Sberro-Soussan R, Vallet-Pichard A, Roque-Afonso AM, Pol S.

Ann Intern Med. 2016 Jun 21;164(12):851-2. doi: 10.7326/L15-0502. Epub 2016 Mar 1. No abstract available.

PMID:
26926359
16.

Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after a dialysis period of less than three years--The PreKit-QoL study protocol.

Sébille V, Hardouin JB, Giral M, Bonnaud-Antignac A, Tessier P, Papuchon E, Jobert A, Faurel-Paul E, Gentile S, Cassuto E, Morélon E, Rostaing L, Glotz D, Sberro-Soussan R, Foucher Y, Meurette A.

BMC Nephrol. 2016 Jan 19;17:11. doi: 10.1186/s12882-016-0225-7.

17.

Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors.

Le Meur Y, Aulagnon F, Bertrand D, Heng AE, Lavaud S, Caillard S, Longuet H, Sberro-Soussan R, Doucet L, Grall A, Legendre C.

Am J Transplant. 2016 Jul;16(7):2181-6. doi: 10.1111/ajt.13698. Epub 2016 Mar 2.

18.

Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up.

Delville M, Sabbah L, Girard D, Elie C, Manceau S, Piketty M, Martinez F, Méjean A, Legendre C, Sberro-Soussan R.

PLoS One. 2015 Jun 24;10(6):e0131237. doi: 10.1371/journal.pone.0131237. eCollection 2015.

19.

[Current aspects of acute humoral rejection].

Legendre C, Loupy A, Rabant M, Aubert O, Rabaté C, Delville M, Tinel C, Amrouche L, Martinez F, Snanoudj R, Bererhi L, Scemla A, Sberro-Soussan R, Duong JP, Suberbielle C, Anglicheau D.

Nephrol Ther. 2014 Nov;10(6):479-83. doi: 10.1016/j.nephro.2014.09.001. Epub 2014 Oct 16. Review. French.

PMID:
25440942
20.

Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies.

Aubert O, Bories MC, Suberbielle C, Snanoudj R, Anglicheau D, Rabant M, Martinez F, Scemla A, Legendre C, Sberro-Soussan R.

Am J Transplant. 2014 Jun;14(6):1439-45. doi: 10.1111/ajt.12709. Epub 2014 May 7.

21.

Autoimmune neutropenia after kidney transplantation: a disregarded entity of posttransplant neutropenia.

Aubert O, Sberro-Soussan R, Scemla A, Casadevall N, Teyssandier I, Martinez F, Hermine O, Legendre C, Varet B, De Fontbrune FS.

Transplantation. 2014 Apr 15;97(7):725-9. doi: 10.1097/TP.0000000000000109.

PMID:
24598937
22.

The kidney as a reservoir for HIV-1 after renal transplantation.

Canaud G, Dejucq-Rainsford N, Avettand-Fenoël V, Viard JP, Anglicheau D, Bienaimé F, Muorah M, Galmiche L, Gribouval O, Noël LH, Satie AP, Martinez F, Sberro-Soussan R, Scemla A, Gubler MC, Friedlander G, Antignac C, Timsit MO, Onetti Muda A, Terzi F, Rouzioux C, Legendre C.

J Am Soc Nephrol. 2014 Feb;25(2):407-19. doi: 10.1681/ASN.2013050564. Epub 2013 Dec 5.

23.

Successful treatment of acute thrombotic microangiopathy by eculizumab after combined lung and kidney transplantation.

Commereuc M, Karras A, Amrein C, Boussaud V, Sberro-Soussan R, Guillemain R, Bacchi VF, Thervet E.

Transplantation. 2013 Oct 27;96(8):e58-9. doi: 10.1097/TP.0b013e3182a7fccd. No abstract available.

PMID:
24132114
24.

FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review.

Soussan M, Abisror N, Abad S, Nunes H, Terrier B, Pop G, Eder V, Valeyre D, Sberro-Soussan R, Guillevin L, Dhote R, Fain O, Mekinian A.

Autoimmun Rev. 2014 Feb;13(2):125-31. doi: 10.1016/j.autrev.2013.09.009. Epub 2013 Oct 9. Review.

PMID:
24121046
25.

Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes.

Canaud G, Kamar N, Anglicheau D, Esposito L, Rabant M, Noël LH, Guilbeau-Frugier C, Sberro-Soussan R, Del Bello A, Martinez F, Zuber J, Rostaing L, Legendre C.

Am J Transplant. 2013 Aug;13(8):2179-85. doi: 10.1111/ajt.12319. Epub 2013 Jun 13.

26.

Eculizumab in renal transplantation.

Legendre C, Sberro-Soussan R, Zuber J, Rabant M, Loupy A, Timsit MO, Anglicheau D.

Transplant Rev (Orlando). 2013 Jul;27(3):90-2. doi: 10.1016/j.trre.2013.04.002. Epub 2013 Jun 7. Review.

PMID:
23747093
27.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.

N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.

28.

The case | Post-tranplant allograft dysfunction.

Aubert O, Galmiche L, Rozenberg F, Duquesne A, Scemla A, Rabant M, Leruez M, Laude H, Legendre C, Sberro-Soussan R.

Kidney Int. 2013 Apr;83(4):765-7. doi: 10.1038/ki.2013.1. No abstract available.

29.

Acute renal failure and volume overload syndrome secondary to a femorofemoral arteriovenous fistula angioplasty in a kidney transplant recipient.

Bertrand D, Desbuissons G, Pallet N, Sartorius A, Legendre C, Mamzer MF, Sberro Soussan R.

Case Rep Transplant. 2013;2013:197524. doi: 10.1155/2013/197524. Epub 2013 Feb 26.

30.

Sirolimus therapy may cause cardiac tamponade.

Bertrand D, Desbuissons G, Pallet N, Debure A, Sartorius A, Anglicheau D, Mamzer MF, Legendre C, Sberro-Soussan R.

Transpl Int. 2013 Feb;26(2):e4-7. doi: 10.1111/tri.12025. Epub 2012 Nov 29.

31.

Home and office blood pressure monitoring in renal transplant recipients.

Sberro-Soussan R, Rabant M, Snanoudj R, Zuber J, Bererhi L, Mamzer MF, Legendre C, Thervet E.

J Transplant. 2012;2012:702316. doi: 10.1155/2012/702316. Epub 2012 Apr 17.

32.

New insights into postrenal transplant hemolytic uremic syndrome.

Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Frémeaux-Bacchi V, Legendre C.

Nat Rev Nephrol. 2011 Jan;7(1):23-35. doi: 10.1038/nrneph.2010.155. Epub 2010 Nov 23. Review.

PMID:
21102542
33.

Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies.

Sberro-Soussan R, Zuber J, Suberbielle-Boissel C, Candon S, Martinez F, Snanoudj R, Rabant M, Pallet N, Nochy D, Anglicheau D, Leruez M, Loupy A, Thervet E, Hermine O, Legendre C.

Am J Transplant. 2010 Mar;10(3):681-6. doi: 10.1111/j.1600-6143.2009.02968.x. Epub 2010 Feb 1.

34.

Bortezomib alone fails to decrease donor specific anti-HLA antibodies: even after one year post-treatment.

Sberro-Soussan R, Zuberl J, Suberbielle-Boissel C, Legendre C.

Clin Transpl. 2010:409-14.

PMID:
21696059
35.

Bortezomib alone fails to decrease donor specific anti-HLA antibodies: 4 case reports.

Sberro-Soussan R, Zuber J, Suberbielle-Boissel C, Legendre C.

Clin Transpl. 2009:433-8.

PMID:
20524311
36.

[Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions].

Snanoudj R, Martinez F, Sberro Soussan R, Thervet E, Legendre C.

Nephrol Ther. 2008 Oct;4 Suppl 3:S192-9. doi: 10.1016/S1769-7255(08)74234-2. Review. French.

PMID:
19000886

Supplemental Content

Loading ...
Support Center